- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 45 Years - 99 Years
- Sexes
- All
Treats Adults
Dominick J Angiolillo, MD, PhD
Cardiologist, Interventional Cardiologist
Dominick J Angiolillo, MD, PhD
- Additional languages:
- Italian,
- Spanish
(904) 383-1011
Request appointment online
Research at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 416 publications
- Percutaneous Coronary Intervention , 211 publications
- Clopidogrel , 189 publications
- Ticlopidine , 158 publications
Research activity
Active clinical trials
- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All
- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 18 Years - 65 Years
- Sexes
- All
My publications
Filter publications
844 publications
2025
Antiplatelet Monotherapies for Long-Term Secondary Prevention Following Percutaneous Coronary Intervention.
Journal of clinical medicine
鈥�2025
Antiplatelet therapy following conservatively managed spontaneous coronary artery dissection.
Journal of thrombosis and thrombolysis
鈥�2025
Aspirin or P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes.
JACC. Cardiovascular interventions
鈥�2025
Cardiovascular Research Technologies 2025: Beyond the Guidelines: DAPT selection and duration before and after PCI.
Cardiovascular revascularization medicine : including molecular interventions
鈥�2025
Characterizing high-risk enrollment criteria and impact on clinical outcomes in a large randomized clinical trial: Insights from the TWILIGHT trial.
American heart journal
鈥�